Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $160.0000 (-5.88%) ($157.5000 - $172.5000) on Wed. Apr. 4, 2012. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.23% (three month average) | RSI | 15 | Latest Price | $160.0000(-5.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -8.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -14.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(5%) IWM(4%) EWP(3%) XAR(3%) XOP(3%) | Factors Impacting CAPR price | CAPR will decline at least -3.115% in a week (0% probabilities). EMHY(-6%) IGOV(-2%) REMX(-1%) EWY(-1%) XLU(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.115% (StdDev 6.23%) | Hourly BBV | 0 () | Intraday Trend | -7.2% | | | |
|
Resistance Level | $249.88 | 5 Day Moving Average | $200(-20%) | 10 Day Moving Average | $227.48(-29.66%) | 20 Day Moving Average | $249.88(-35.97%) | To recent high | -44.8% | To recent low | 0% | Market Cap | $3.152b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |